Understanding the Opioid Overdose Crisis: A Comprehensive Bibliometric Analysis
Tawfeeq Altherwi
International Journal of Pharmacology ›› 2025, Vol. 21 ›› Issue (5) : 44192
Opioid overdose represents a critical public health issue that has attracted considerable research interest. Therefore, objective of this study aimed to conduct a comprehensive analysis of the opioid overdose research (OOR) landscape, performance, evolution, citation impact and changing research themes.
A bibliometric analysis was performed on the OOR data published between, 1971 and 2024. Data were gathered from the Scopus database and analyzed using Bibliometrix and VOSviewer. Citation counts, prolific authors, top sources, and seminal publications were also identified. Thematic mapping was performed to aid the visualization of the major clusters in the OOR data.
The analysis included 13,971 authors who contributed to the OOR. Prolific authors, such as Walley, A.Y., and Green, T.C., made notable contributions. "Drug and alcohol dependence" emerged as the top source in the publications. The United States exhibited the highest research output, followed by Canada, the United Kingdom, and Australia. The average citation count per article was 22.44, indicating the impact and visibility of the research. Seminal publications have addressed critical topics including opioid prescription patterns, economic burden, medication-assisted therapies, and overdose prevention programs. Thematic mapping revealed clusters related to drug overdose, opioids, overdose prevention, toxicology, buprenorphine, and opioid use disorders.
The findings showed an ongoing need for further studies on gap filling, such as long-term consequences, socioeconomic factors and inequalities, in addition to technology application and interdisciplinary collaboration. By focusing on new themes, as well as longitudinal studies, stakeholders can gain improved knowledge on opioid overdose problem-solving solutions that have been applied to victims and their communities, thereby improving outcomes.
opioid overdose / toxicity / research landscape / emerging research / bibliometric analysis
| [1] |
Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Archives of Internal Medicine. 2011; 171: 686–691. https://doi.org/10.1001/archinternmed.2011.117. |
| [2] |
Bohnert ASB, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011; 305: 1315–1321. https://doi.org/10.1001/jama.2011.370. |
| [3] |
Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths–United States, 2000–2014. MMWR. Morbidity and Mortality Weekly Report. 2016; 64: 1378–1382. https://doi.org/10.15585/mmwr.mm6450a3. |
| [4] |
Gomes T, Juurlink DN, Antoniou T, Mamdani MM, Paterson JM, van den Brink W. Gabapentin, opioids, and the risk of opioid-related death: A population-based nested case-control study. PLoS Medicine. 2017; 14: e1002396. https://doi.org/10.1371/journal.pmed.1002396. |
| [5] |
Dettmer K, Saunders B, Strang J. Take home naloxone and the prevention of deaths from opiate overdose: two pilot schemes. BMJ (Clinical Research Ed.). 2001; 322: 895–896. https://doi.org/10.1136/bmj.322.7291.895. |
| [6] |
Green TC, Dauria EF, Bratberg J, Davis CS, Walley AY. Orienting patients to greater opioid safety: models of community pharmacy-based naloxone. Harm Reduction Journal. 2015; 12: 25. https://doi.org/10.1186/s12954-015-0058-x. |
| [7] |
Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug and Alcohol Dependence. 2019; 200: 59–63. https://doi.org/10.1016/j.drugalcdep.2019.03.014. |
| [8] |
Larochelle MR, Bernstein R, Bernson D, Land T, Stopka TJ, Rose AJ, et al. Touchpoints - Opportunities to predict and prevent opioid overdose: A cohort study. Drug and Alcohol Dependence. 2019; 204: 107537. https://doi.org/10.1016/j.drugalcdep.2019.06.039. |
| [9] |
Strang J, Volkow ND, Degenhardt L, Hickman M, Johnson K, Koob GF, et al. Opioid use disorder. Nature Reviews. Disease Primers. 2020; 6: 3. https://doi.org/10.1038/s41572-019-0137-5. |
| [10] |
Sun EC, Dixit A, Humphreys K, Darnall BD, Baker LC, Mackey S. Association between concurrent use of prescription opioids and benzodiazepines and overdose: retrospective analysis. BMJ (Clinical Research Ed.). 2017; 356: j760. https://doi.org/10.1136/bmj.j760. |
| [11] |
Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. Journal of Substance Abuse Treatment. 2013; 44: 241–247. https://doi.org/10.1016/j.jsat.2012.07.004. |
| [12] |
van Lemmen M, Florian J, Li Z, van Velzen M, van Dorp E, Niesters M, et al. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest. Anesthesiology. 2023; 139: 342–353. https://doi.org/10.1097/ALN.0000000000004622. |
| [13] |
Ghanem N, Dromgoole D, Hussein A, Jermyn RT. Review of medication-assisted treatment for opioid use disorder. Journal of Osteopathic Medicine. 2022; 122: 367–374. https://doi.org/10.1515/jom-2021-0163. |
| [14] |
Winograd RP, Presnall N, Stringfellow E, Wood C, Horn P, Duello A, et al. The case for a medication first approach to the treatment of opioid use disorder. The American Journal of Drug and Alcohol Abuse. 2019; 45: 333–340. https://doi.org/10.1080/00952990.2019.1605372. |
| [15] |
Afuye GA, Kalumba AM, Busayo ET, Orimoloye IR. A bibliometric review of vegetation response to climate change. Environmental Science and Pollution Research International. 2022; 29: 18578–18590. https://doi.org/10.1007/s11356-021-16319-7. |
| [16] |
Alkhammash R. Bibliometric, network, and thematic mapping analyses of metaphor and discourse in COVID-19 publications from 2020 to 2022. Frontiers in Psychology. 2023; 13: 1062943. https://doi.org/10.3389/fpsyg.2022.1062943. |
| [17] |
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010; 84: 523–538. https://doi.org/10.1007/s11192-009-0146-3. |
| [18] |
Burnham JF. Scopus database: a review. Biomedical Digital Libraries. 2006; 3: 1. https://doi.org/10.1186/1742-5581-3-1. |
| [19] |
Wang S, Scells H, Koopman B, Zuccon G. Automated MeSH term suggestion for effective query formulation in systematic reviews literature search. Intelligent Systems with Applications. 2022; 16: 200141. https://doi.org/10.1016/j.iswa.2022.200141. |
| [20] |
Aria M, Cuccurullo C. Bibliometrix: An r-tool for comprehensive science mapping analysis. Journal of Informetrics. 2017; 11: 959–975. https://doi.org/10.1016/j.joi.2017.08.007. |
| [21] |
Green TC, Heimer R, Grau LE. Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States. Addiction (Abingdon, England). 2008; 103: 979–989. https://doi.org/10.1111/j.1360-0443.2008.02182.x. |
| [22] |
Strang J, Manning V, Mayet S, Best D, Titherington E, Santana L, et al. Overdose training and take-home naloxone for opiate users: prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction (Abingdon, England). 2008; 103: 1648–1657. https://doi.org/10.1111/j.1360-0443.2008.02314.x. |
| [23] |
Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Annals of Internal Medicine. 2010; 152: 85–92. https://doi.org/10.7326/0003-4819-152-2-201001190-00006. |
| [24] |
Florence CS, Zhou C, Luo F, Xu L. The Economic Burden of Prescription Opioid Overdose, Abuse, and Dependence in the United States, 2013. Medical Care. 2016; 54: 901–906. https://doi.org/10.1097/MLR.0000000000000625. |
| [25] |
Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study. Annals of Internal Medicine. 2018; 169: 137–145. https://doi.org/10.7326/M17-3107. |
| [26] |
Volkow ND, Frieden TR, Hyde PS, Cha SS. Medication-assisted therapies–tackling the opioid-overdose epidemic. The New England Journal of Medicine. 2014; 370: 2063–2066. https://doi.org/10.1056/NEJMp1402780. |
| [27] |
Walley AY, Xuan Z, Hackman HH, Quinn E, Doe-Simkins M, Sorensen-Alawad A, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ (Clinical Research Ed.). 2013; 346: f174. https://doi.org/10.1136/bmj.f174. |
| [28] |
Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY. Expanded access to naloxone among firefighters, police officers, and emergency medical technicians in Massachusetts. American Journal of Public Health. 2014; 104: e7–e9. https://doi.org/10.2105/AJPH.2014.302062. |
| [29] |
Doe-Simkins M, Quinn E, Xuan Z, Sorensen-Alawad A, Hackman H, Ozonoff A, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014; 14: 297. https://doi.org/10.1186/1471-2458-14-297. |
| [30] |
Green TC, Park JN, Gilbert M, McKenzie M, Struth E, Lucas R, et al. An assessment of the limits of detection, sensitivity and specificity of three devices for public health-based drug checking of fentanyl in street-acquired samples. The International Journal on Drug Policy. 2020; 77: 102661. https://doi.org/10.1016/j.drugpo.2020.102661. |
| [31] |
Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, et al. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduction Journal. 2018; 15: 7. https://doi.org/10.1186/s12954-018-0213-2. |
| [32] |
Morgan JR, Schackman BR, Leff JA, Linas BP, Walley AY. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. Journal of Substance Abuse Treatment. 2018; 85: 90–96. https://doi.org/10.1016/j.jsat.2017.07.001. |
| [33] |
Morgan JR, Schackman BR, Weinstein ZM, Walley AY, Linas BP. Overdose following initiation of naltrexone and buprenorphine medication treatment for opioid use disorder in a United States commercially insured cohort. Drug and Alcohol Dependence. 2019; 200: 34–39. https://doi.org/10.1016/j.drugalcdep.2019.02.031. |
| [34] |
Schiff DM, Nielsen T, Terplan M, Hood M, Bernson D, Diop H, et al. Fatal and Nonfatal Overdose Among Pregnant and Postpartum Women in Massachusetts. Obstetrics and Gynecology. 2018; 132: 466–474. https://doi.org/10.1097/AOG.0000000000002734. |
| [35] |
Sherman SG, Morales KB, Park JN, McKenzie M, Marshall BDL, Green TC. Acceptability of implementing community-based drug checking services for people who use drugs in three United States cities: Baltimore, Boston and Providence. The International Journal on Drug Policy. 2019; 68: 46–53. https://doi.org/10.1016/j.drugpo.2019.03.003. |
| [36] |
Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, et al. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addiction (Abingdon, England). 1999; 94: 199–204. https://doi.org/10.1046/j.1360-0443.1999.9421993.x. |
| [37] |
Williams AV, Strang J, Marsden J. Development of Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales for take-home naloxone training evaluation. Drug and Alcohol Dependence. 2013; 132: 383–386. https://doi.org/10.1016/j.drugalcdep.2013.02.007. |
| [38] |
Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP. The Opioid Epidemic in the United States. Emergency Medicine Clinics of North America. 2016; 34: e1–e23. https://doi.org/10.1016/j.emc.2015.11.002. |
| [39] |
Des Jarlais DC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduction Journal. 2017; 14: 51. https://doi.org/10.1186/s12954-017-0178-6. |
| [40] |
Cottler LB, Green AI, Pincus HA, McIntosh S, Humensky JL, Brady K. Building capacity for collaborative research on opioid and other substance use disorders through the Clinical and Translational Science Award Program. Journal of Clinical and Translational Science. 2019; 4: 81–89. https://doi.org/10.1017/cts.2019.441. |
| [41] |
Sud A, Cheng DK, Moineddin R, Zlahtic E, Upshur R. Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction: exploring the origins of the North American opioid crisis. Scientometrics. 2021; 126: 8935–8955. https://doi.org/10.1007/s11192-021-04154-z. |
| [42] |
Klabunde CN, Walton L, Shropshire KL, Ganoza LF, Hession J, Schwartz K, et al. Opioids and Chronic Pain: Impact of the NIH Pathways to Prevention Evidence-Based Workshop Program. Prevention Science: the Official Journal of the Society for Prevention Research. 2023; 24: 1091–1101. https://doi.org/10.1007/s11121-023-01563-9. |
| [43] |
Kurexi S, Wang K, Chen T. Knowledge Mapping of Opioids and Immunomodulation: A Bibliometric Analysis (2000–2022). Journal of Pain Research. 2023; 16: 1499–1515. https://doi.org/10.2147/JPR.S401326. |
| [44] |
Chen AMH, Kleppinger EL, Churchwell MD, Rhoney DH. Examining Competency-Based Education Through the Lens of Implementation Science: A Scoping Review. American Journal of Pharmaceutical Education. 2024; 88: 100633. https://doi.org/10.1016/j.ajpe.2023.100633. |
| [45] |
Balis LE, Houghtaling B. Matching barriers and facilitators to implementation strategies: recommendations for community settings. Implementation Science Communications. 2023; 4: 144. https://doi.org/10.1186/s43058-023-00532-1. |
| [46] |
Hartmann RJ, Elder JD, Terrett LA. Impact of an emergency department opioid prescribing guideline on emergency physician behaviour and incidence of overdose in the Saskatoon Health Region: a retrospective pre-post implementation analysis. CMAJ Open. 2021; 9: E79–E86. https://doi.org/10.9778/cmajo.20200071. |
/
| 〈 |
|
〉 |